Beta Blocker Use In Traumatic Brain Injury Based On The High-Sensitive Troponin T Status
Clinical trial NCT04508244 · UNKNOWN
Trial details
- NCT number
- NCT04508244
- Sponsor
- Hamad Medical Corporation
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-29
- Primary completion
- 2024-12-31
- Enrollment
- 771
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.